HALO - Halozyme Therapeutics' (HALO) CEO Helen Torley On Q3 2020 Results - Quick Version Earnings Call Transcript

Halozyme Therapeutics, Inc. (HALO) Q3 2020 Earnings Conference Call October 02, 2020 4:20 PM ET Company Participants Al Kildani – Vice President-Investor Relations and Corporate Communications Helen Torley – President and Chief Executive Officer Elaine Sun – Chief Financial Officer Conference Call Participants Charles Duncan - Cantor Fitzgerald Jim Birchenough – Wells Fargo Joe Kim - BMO Capital Markets Jason Butler - JMP Group LLC Joe Catanzaro - Piper Sandler Joel Beatty - Citi Presentation Disclaimer: *NEW* We are providing this transcript version in a raw, machine-assisted format and it is unaudited. Please reference the audio for any questions on the content. A standard transcript will be available later on the site per our normal procedure. Please enjoy this timely version in the interim. Operator [00:00:06] Ladies and gentlemen, thank you for standing by and welcome to the Halozyme third quarter twenty twenty financial results conference call. At this time,

For further details see:

Halozyme Therapeutics' (HALO) CEO Helen Torley On Q3 2020 Results - Quick Version Earnings Call Transcript